Haemodialysis-associated amyloidosis
Haemodialysis-associated amyloidosis | |
ICD-10 | E85.3 |
---|---|
ICD-9 | 277.3 |
eMedicine | med/3384 |
Haemodialysis-associated amyloidosis is a form of amyloidosis associated with chronic renal failure.[1]
Presentation
Long term haemodialysis results in a gradual accumulation of β2 microglobulin, a serum protein, in the blood. It accumulates because it is unable to cross the dialysis filter.
Prevention
Low copper dialysis is theorized to prevent or delay onset.[2]
References
- ↑ Miyata T, Oda O, Inagi R; et al. (1993). "beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis". J. Clin. Invest. 92 (3): 1243–52. PMC 288264 Freely accessible. PMID 8376584. doi:10.1172/JCI116696.
- ↑ "BU".
Amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Haemodialysis-associated amyloidosis On the Web |
American Roentgen Ray Society Images of Haemodialysis-associated amyloidosis |
Risk calculators and risk factors for Haemodialysis-associated amyloidosis |